PharmaVOICE - 
February 2012
Purchase Issue

In Every Issue
Last Word
Creating Jobs in the Industry Safi Bahcall, Ph.D., CEO, Synta [...]
By

Safi Bahcall, Ph.D., CEO, Synta Pharmaceuticals

Talent Pool
executive appointments and promotions in the healthcare industry By Carolyn [...]
By

Carolyn Gretton

PharmaTrax
Sales, marketing, And R&D?Trends affecting the healthcare industry By Carolyn [...]
By

Carolyn Gretton

Social Media
Social Media trends, regs, and apps By Robin Robinson Palio [...]
By

Robin Robinson

Tools of the Trade
New electronic and web-based applications, sites, and technologies By Carolyn [...]
By

Carolyn Gretton

What’s New
New healthcare-related products, services, and companies By Carolyn Gretton New [...]
By

Carolyn Gretton

UpFront
INDUSTRY at Large Milestones… Spectrum Celebrates 15 Years Spectrum, a [...]
By

Taren Grom, Editor

Letter from the Editor
New commercial models paying dividends… Creating value — the goal [...]
By

Taren Grom, Editor

On The Cover

Safety and Pharmacovigilance: A Moving Target
Robin Robinson The industry has always been under ­extreme scrutiny by regulators and the ­public, but the current business ­environment creates even more pressure on the pharmaceutical industry to stay compliant. Regulations and procedures are not only tightening but continually developing and changing in the United States and abroad. Keeping on top of compliance in [...]
By

Robin Robinson

Features

Outsourcing: Enhance, Support, Grow
You cannot do today’s job with yesterday’s methods and be in business tomorrow.” The wise words of Nelson Jackson should be the driving force behind every outsourcing partnership today. Implementing innovative strategies through outsourcing helps pharmaceutical companies meet the changing demands of the marketplace and realize their long-term goals. There might be some uncertainties around [...]
By

Erin Neary and Dennis McLoughlin, The Remedy Group

Commercialization – Decisions, Decisions, Decisions
In recent years, the research and development landscape in the pharmaceutical industry has radically changed. The search for the next big blockbuster has been replaced by the search for medicines targeted toward specific patient subpopulations or toward diseases with high unmet medical need to make up the gaping hole left by blockbuster patent expiries. To [...]
By

Dr. Michael Ackerman, Quintiles

Pharmaceutical Call Centers Build relationships with Healthcare Providers and Patients
Pharmaceutical, biotechnology, and medical device companies have a significant need to build relationships with prescribers and patients. However, these audiences have very different needs that require companies to take varying approaches to communicate effectively with them. Healthcare providers are under tremendous pressure to see as many patients as possible each day, and they have very [...]
By

Lou Shapiro, PhoneScreen, an AMAC company

The Emergence of Strategic Outsourcing in Clinical Supply Chain Management
Ten years ago few biopharmaceutical industry professionals could have predicted how broadly the landscape for outsourcing would change by 2012. Most companies were outsourcing in a tactical, project-by-project manner and utilizing dozens of providers across functional areas. Some were moving to a “preferred provider” model in which five to 10 providers were being used for [...]
By

Robert Dunlop, Almac Clinical Services and Jim Murphy, Almac Clinical technologies

Why Outsourcing Patient Enrollment to a Specialist Makes Sense
Richard Malcolm, Ph.D., CEO, Acurian Disruptive change is needed in clinical trial management, an industry where inadequate enrollment has become the biggest driver of wasted dollars. The cost of patient enrollment is now the single largest part of the total trial budget, representing 32% of the cost. Among CROs and sponsors, this expense has been [...]
By

Richard Malcolm, Ph.D., CEO, Acurian

SHOWCASE FEATURE: Help from The Outside
Help from the Outside Showcase Feature: Outsourcing Carolyn Gretton As life-sciences companies look to improve operational efficiencies within their organizations, they are increasingly reducing the number of activities that they would categorize as core competencies and ­outsourcing them to third-party partners. “Successful outsourcing depends upon well-defined objectives and deliverables, a clear understanding of respective roles [...]
By

Carolyn Gretton

Trends, Challenges, and Best Practices of Global Product Launches
Companies both large and small are expanding their global launch approach. Robin Robinson With all the variances and complexities involved in launching a product globally, especially around regulatory and approval requirements within various regions across countries, one could argue that there is nothing really global about a global launch. Instead, it is more a region-by-region [...]
By

Robin Robinson

C-Suite CROs
Insights from the C-Suite: Contract Research Organizations CRO growth continues to outpace other sectors. Frost &?Sullivan estimates that the CRO market earned revenue of .43 billion in 2010 and estimates that the sector will top .09 billion in 2017. According to a recent Frost & Sullivan report, the U.S. CRO market bucked the trend amidst [...]
By

Taren Grom, Editor

Transformative Leadership
Taren Grom Dr. Deborah Dunsire, President and CEO of Millennium: The Takeda Oncology Company, is leading her company to achieve an audacious goal: curing cancer. We are what we repeatedly do…excellence, then, is not so much an act, but a habit.” This Aristotle quote is one of Deborah Dunsire, M.D.’s favorite expressions. As president and [...]
By

Taren Grom, Editor

UK Revival: Rebuilding a Life Sciences World Leader
Kim Ribbink A long history as a world leader in innovation, talented scientists from well-respected ­ universities, mature biotech clusters, and government incentives to attract innovative ­companies give the U.K. a clear edge, but this great scientific nation still has challenges with which to contend. The United Kingdom life-sciences industry is one of the world [...]
By

Kim Ribbink

What’s Ahead for Biosimilars
Denise Myshko Uncertainty lies ahead for the biosimilar market, as manufacturers await FDA guidance. Biosimilars could represent a multi-billion dollar market in the United States, although some questions remain, including the uptake by physicians and payers, pricing of biosimilars, and how the Food and Drug Administration will review such products. Alan Sheppard, global head of [...]
By

Denise Myshko

Generics: Front and Center
The generic drug era is impacting all areas of the ­ industry as the demand for cost-effective medications increases. Denise Myshko As the demand for generics increases, originator companies are moving beyond the traditional end-of-cycle strategies and are deploying more aggressive tactics to not only protect their brands but to market their own generics. David [...]
By

Denise Myshko

Digital Patient-Centric Communications: Listen and Learn
Learning to listen and listening to learn are critical to a successful social networking marketing plan. While the buzzword in marketing these days is patient-centric, the industry still struggles with shifting its focus from products to consumers. Years of pushing product messaging out into the universe has conditioned the industry to turn a deaf ear [...]
By

Robin Robinson

FEEDBACK